Effect of coenzyme Q10 on the disposition of doxorubicin in rats.

Abstract:

:The effect of exogenous coenzyme Q10 (CoQ10) on the pharmacokinetic profiles and biliary excretion of doxorubicin and its main metabolites, doxorubicinol and doxorubicinolone, was investigated in rats. No statistically significant changes in the pharmacokinetic parameters of doxorubicin was observed following the intravenous bolus administration of 10 mg/kg doxorubicin to rats during a 6-day oral regimen of CoQ10 (20 mg/kg daily). Treatment with CoQ10 did not affect the formation of the doxorubicinol, but produced a 75% increase (P < 0.05) in the AUC of doxorubicinolone. Correspondingly, CoQ10 had no apparent effect on the biliary excretion of doxorubicin and formation clearance of doxorubicinol, whereas the formation clearance of doxorubicinolone was significantly increased by 69% in CoQ10-pretreated rats (P < 0.05). Overall, the results suggest that CoQ10 treatment has no significant effect on the pharmacokinetics of doxorubicin and the formation of the cytotoxic metabolite, doxorubicinol.

authors

Zhou Q,Chowbay B

doi

10.1007/BF03190456

keywords:

subject

Has Abstract

pub_date

2002-07-01 00:00:00

pages

185-92

issue

3

eissn

0378-7966

issn

2107-0180

journal_volume

27

pub_type

杂志文章
  • Pharmacokinetic evaluation of guar gum-based colon-targeted oral drug delivery systems of metronidazole in healthy volunteers.

    abstract::The present study was carried out to find the in vivo performance of guar gum-based colon-targeted tablets of metronidazole as compared to an immediate release tablets in human volunteers. Six healthy volunteers participated in the study and a crossover design was used. Blood samples were obtained at different time in...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF03220181

    authors: Krishnaiah YS,Veer Raju P,Dinesh Kumar B,Jayaram B,Rama B,Raju V,Bhaskar P

    更新日期:2003-10-01 00:00:00

  • Pharmacogenetics of Cannabinoids.

    abstract::Although the application of medical marijuana and cannabinoid drugs is controversial, it is a part of modern-day medicine. The list of diseases in which cannabinoids are promoted as a treatment is constantly expanding. Cases of significant improvement in patients with a very poor prognosis of glioma or epilepsy have a...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,评审

    doi:10.1007/s13318-017-0416-z

    authors: Hryhorowicz S,Walczak M,Zakerska-Banaszak O,Słomski R,Skrzypczak-Zielińska M

    更新日期:2018-02-01 00:00:00

  • Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers.

    abstract::This study examined the effects of the absorption enhancers, acylcarnitines, on efflux transporting systems, including P-glycoprotein (P-gp) and other efflux transporters, and elucidated the importance of acyl chain length and the concentration of acylcarnitine on the activity of efflux transport. The effects of two a...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-010-0001-1

    authors: Tomita M,Doi N,Hayashi M

    更新日期:2010-09-01 00:00:00

  • Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.

    abstract:BACKGROUND AND OBJECTIVES:Ketoprofen, a potent nonsteroidal anti-inflammatory drug, is clinically administered as a racemic mixture. One of the possible metabolism routes of ketoprofen is the inversion of the R- to S-enantiomer in the gastrointestinal tract. Ketoprofen, as a weak acid drug, might undergo recirculation ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s13318-015-0313-2

    authors: Lorier M,Magallanes L,Ibarra M,Guevara N,Vázquez M,Fagiolino P

    更新日期:2016-12-01 00:00:00

  • Effects of potassium ethylxanthogenate and 2,3-dimercaptopropane sulphonate sodium on the pentobarbital pharmacokinetics and metabolism in male mice.

    abstract::The effects of potassium ethylxanthogenate (PEX) and 2,3-Dimercaptopropane sulphonate sodium (Unithiol) on the pentobarbital (40 mg/kg, body weight i.v.) (PB) sleeping time, pharmacokinetics, and metabolism, were studied in comparative experiments on male albino mice. It was established that the pretreatment of animal...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189539

    authors: Yanev S,Janku I,Stoytchev T,Havlik I,Krebs V

    更新日期:1982-01-01 00:00:00

  • A rapid determination of drug candidate tyrosol galactoside in rat plasma by HPLC and its application to the pharmacokinetics study.

    abstract::A simple and sensitive HPLC method has been developed and validated for the determination of tyrosol galactoside (TG) in rat plasma. After one-step protein precipitation with methanol, plasma samples were separated on an Ultimate AQ-C18 column (150 mm×4.6 mm, 5 μm) using acetonitrile-water (7:93, v/v) as mobile phase ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-010-0015-8

    authors: Wang Q,Wang Y,Deng Y,Shi T,Liu X,Sun X,Li X,Zhou D

    更新日期:2011-01-01 00:00:00

  • Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.

    abstract::Mathematical models that can predict the kinetics of compounds have been increasingly adopted for drug development and risk assessment. Data for these models may be generated from in vitro experimental systems containing enzymes contributing to metabolic clearance, such as subcellular tissue fractions including micros...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-020-00666-w

    authors: Doerksen MJ,Jones RS,Coughtrie MWH,Collier AC

    更新日期:2020-12-19 00:00:00

  • Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy--does structural design, dosing and induction strategies have a role to play?

    abstract::Recent evidences suggest that genetic CYP2C19 polymorphism plays a role in the development of treatment resistance for clopidogrel's antiplatelet therapy. This short communication puts forward some strategies that could be potentially used to overcome the genetic polymorphism associated hurdles. While there is some es...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03191165

    authors: Srinivas NR

    更新日期:2009-07-01 00:00:00

  • Hydrolysis of haloperidol decanoate in vitro by cultured cells.

    abstract::[14C]Haloperidol decanoate was hydrolysed by partially purified carboxylesterase but not in plasma, blood, lymph and lymphatic liquid. These fluids inhibited the enzyme-mediated hydrolysis of the ester. Within the same incubation period as above, the ester was found hydrolysed to various extents in cell cultures of is...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189895

    authors: Oh-e Y,Miyazaki H,Matsunaga Y,Nambu K,Kobayashi N,Hashimoto M

    更新日期:1987-07-01 00:00:00

  • Combining Chemical Permeation Enhancers for Synergistic Effects.

    abstract::Currently, macromolecular drugs such as proteins are mainly administered by means of injections due to their low intestinal epithelial permeability and poor stability in the gastrointestinal tract. This study investigated binary combinations of chemical drug absorption enhancers to determine if synergistic drug absorp...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-015-0280-7

    authors: du Toit T,Malan MM,Lemmer HJ,Gouws C,Aucamp ME,Breytenbach WJ,Hamman JH

    更新日期:2016-10-01 00:00:00

  • Disposition of 3H-labelled buserelin continuously infused into rats.

    abstract::The disposition of the gonadotropin-releasing hormone (GnRH) agonist buserelin was studied in male rats under conditions of long-term administration. Rats were continuously infused with about 30 pmole [3H]-buserelin/24 h subcutaneously by osmotic minipumps for 4-7 days. After killing the rats, the 3H-activity of the t...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189737

    authors: Heinrich N,Albrecht E,Sandow J,Kertscher U,Lorenz D,Oehlke J,Berger H

    更新日期:1996-10-01 00:00:00

  • Relative bioavailability and bioequivalence of metforphin hydrochloride extended-released and immediate-released tablets in healthy Chinese volunteers.

    abstract::The aim of the present study was to investigate the relative bioavailability and bioequivalence of a new tablet formulation of metformin hydrochloride with reference to a standard product in healthy Chinese adult male volunteers. Two randomized, comparative, two-way crossover studies were therefore conducted. In study...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/BF03190986

    authors: Li J,Jin Y,Wang TY,Lü XW,Li YH

    更新日期:2007-01-01 00:00:00

  • Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.

    abstract:BACKGROUND AND OBJECTIVES:Gadobenate dimeglumine (Gd-BOPTA) is a commercialised hepatobiliary contrast agent used during liver magnetic resonance imaging (MRI) to detect liver diseases. It enters into human hepatocytes through organic anion transporting polypeptides (OATP1B1/B3) and crosses the canalicular transporter ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-016-0382-x

    authors: Daire JL,Leporq B,Vilgrain V,Van Beers BE,Schmidt S,Pastor CM

    更新日期:2017-08-01 00:00:00

  • A population approach to the forecasting of amikacin plasma and urinary levels using a prescribed dosage regimen.

    abstract::We retrospectively analyzed amikacin pharmacokinetics in 19 critically ill patients who received amikacin intravenously. Fourteen subjects (577 serum amikacin concentrations, 167 urine measurements) were studied to obtain data for population modeling, while 5 patients (267 serum amikacin concentrations, 68 urine measu...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190009

    authors: Joubert P,Bressolle F,Gouby A,Douçot PY,Saissi G,Gomeni R

    更新日期:1999-01-01 00:00:00

  • Solid-phase extraction of piribedil and its metabolites from plasma and urine without and after deconjugation, by high performance liquid chromatography.

    abstract::A new high performance liquid chromatographic procedure has been developed for the simultaneous quantification of piribedil (PD) and its three main basic metabolites in rat plasma and urine, without and after hydrolysis. The procedure relies on isolation of the compounds from plasma and urine constituents using the Se...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190147

    authors: Sarati S,Caccia S

    更新日期:1992-07-01 00:00:00

  • Metabolism of cisplatin in the organs of Rattus norvegicus: role of Glutathione S-transferase P1.

    abstract::Glutathione S-transferases (GSTs) play an important role in the biotransformation of endogenous compounds and xenobiotics as well as in the metabolic inactivation of pharmacologically active substances, including anticancer drugs. Using cisplatin as the prototype drug, we investigated if any correlation exists between...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-014-0176-y

    authors: Nagar R,Khan AR,Poonia A,Mishra PK,Singh S

    更新日期:2015-03-01 00:00:00

  • Oxiracetam pharmacokinetics following single and multiple dose administration in the elderly.

    abstract::The kinetics of the nootropic drug oxiracetam was studied in 6 elderly female patients (age range 69-96 years) in good physical condition. After a single oral dose (800 mg), serum oxiracetam levels reached a peak (25 +/- 6 micrograms/ml) within 1-3 h and declined thereafter with a half-life of 3 to 6 h. Eighty-four pe...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189889

    authors: Perucca E,Parini J,Albrici A,Visconti M,Ferrero E

    更新日期:1987-04-01 00:00:00

  • Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide.

    abstract::The disposition kinetics of the N-oxide of picobenzide were studied after administration to rabbits at a bolus dose of 30 mg/kg of picobenzide intravenously. The biotransformation process fits a first-order kinetic process, and the metabolite shows good access capacity to the peripheral compartment. The N-oxide of pic...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190837

    authors: Santos Buelga D,Mariño EL,Domínguez-Gil A

    更新日期:1989-01-01 00:00:00

  • A comparative "in vitro" study of permeability with different synthetic and biological membranes.

    abstract::Permeability coefficients of seven compounds belonging to a true homologous series (4-alkylanilines) through several different synthetic and biological membranes were assayed in a two-chamber diffusion cell. Permeability-lipophilicity relationships for the experimental data were established and compared in order to as...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Díez-Sales O,Guzmán D,Cano D,Martín A,Sánchez E,Herráez M

    更新日期:1991-01-01 00:00:00

  • Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study.

    abstract:BACKGROUND AND OBJECTIVES:Hydronidone is a novel pyridine derivative with therapeutic potential for hepatic fibrosis. The aim of this study was to investigate the safety, tolerability, and pharmacokinetics of hydronidone in healthy subjects. Effects of sex and food on hydronidone pharmacokinetics were also evaluated. ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s13318-015-0316-z

    authors: Liu Y,Wu J,Li Z,Luo Y,Zeng F,Shi S

    更新日期:2017-02-01 00:00:00

  • On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation.

    abstract:BACKGROUND AND OBJECTIVES:Previous studies reported that tapentadol-sulfate represented one of the major metabolites of tapentadol excreted in urine. The current study aimed to identify the human cytosolic sulfotransferases (SULTs) that is(are) capable of sulfating tapentadol and to examine whether human cells and huma...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-016-0392-8

    authors: Bairam AF,Rasool MI,Kurogi K,Liu MC

    更新日期:2017-10-01 00:00:00

  • Comparative bioavailability of two immediate release tablets of cisapride in healthy volunteers.

    abstract::Relative bioavailability of cisapride was investigated after oral administration of a test versus a reference formulation of immediate release tablets of cisapride, both with 10 mg per unit. The study was conducted in a two-way cross-over design, as a single dose open-label randomised trial. The two formulations were ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF03192297

    authors: Maya MT,Domingos CR,Guerreiro MT,Filipe AP,Morais JA

    更新日期:1998-07-01 00:00:00

  • Bioequivalence studies: biometrical concepts of alternative designs and pooled analysis.

    abstract::A bioequivalence study compares the bioavailability between a test and a reference drug product in terms of the rate and extent of drug absorption. Area under the plasma concentration-time curve (AUC) and maximum plasma concentration (Cmax) are the pharmacokinetic parameters that serve as characteristics for the asses...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190024

    authors: Zintzaras E,Bouka P

    更新日期:1999-07-01 00:00:00

  • Disposition of epirubicin in an oily contrast medium after intravenous and intrahepato-arterial administration in liver cancer: a preliminary report.

    abstract::The present study reports findings on the disposition of epirubicin after an intrahepato-arterial administration of the Lipiodol-drug complex, prepared by mixing the drug-aqueous phase with the iodized oil by ultra-sonification, in 14 patients with histologically proven hepatoma or hepatomegaly with serum alpha-fetopr...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190149

    authors: Lee K,Chan K,Leung WT,Leung NW,Ho S,Chan M,Lau CC,Tao M,Lau WY,Shiu W

    更新日期:1992-07-01 00:00:00

  • Multiplicative dependence of the first order rate constant and its impact on clinical pharmacokinetics and bioequivalence.

    abstract::The purpose of the study was to investigate the factors upon which the first order rate constant depends in order to assess the impact on the body-drug concentration when it changes throughout a treatment. A reasoning for linking the first order rate constants with several factors in a multiplicative way was proposed ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190573

    authors: Fagiolino P

    更新日期:2004-01-01 00:00:00

  • Hepatic metabolism of doxorubicin in mice and rats.

    abstract::We have studied the metabolism of doxorubicin in rat and mouse liver, heart and hepatocytes. Doxorubicinol was present in all cases at very low levels and 7-deoxyaglycones were present only in extraphysiological conditions: no aglycones were found either in fresh livers or in hearts of animals treated with the drug, b...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189834

    authors: Vrignaud P,Londos-Gagliardi D,Robert J

    更新日期:1986-04-01 00:00:00

  • Improvement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000.

    abstract::The present investigation was designed and undertaken in order to substantiate further contention concerning the universality of the utilization of PEG polymers as matrix carriers. This study could then be considered an attempt to enhance the dissolution rate of triamterene, with the subsequent enhancement in its abso...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188855

    authors: Arias MJ,Gines JM,Moyano JR,Perez-Barrales MJ,Vela MT,Rabasco AM

    更新日期:1994-10-01 00:00:00

  • Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.

    abstract::The pharmacokinetics of midazolam and of its main metabolite, 1-hydroxymidazolam, were investigated in intensive care patients after intravenous bolus of 0.2 mg/kg followed by a 0.1 mg/kg/h intravenous infusion of midazolam over 2 hours. A wide interpatient variability of the main pharmacokinetic parameters of midazol...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189348

    authors: Boulieu R,Lehmann B,Salord F,Fisher C,Morlet D

    更新日期:1998-04-01 00:00:00

  • Pharmacokinetic studies of flumecinol in man and dog.

    abstract::The pharmacokinetics of flumecinol (Zixoryn) a new hepatic enzyme inducer has been studied in four beagle dogs and six healthy volunteers. The beagle dogs and the volunteers received the drug orally in a dose of 40 mg/kg of body weight and of 100 mg single dose respectively. Flumecinol was extracted from plasma with d...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188725

    authors: Klebovich I,Vereczkey L,Kerpel-Fronius S,Ringwald G,Bodrogligeti I

    更新日期:1982-01-01 00:00:00

  • Urodynamic modeling of norfloxacin pharmacokinetics by means of computer simulation.

    abstract::Urodynamic model was developed which, in conjunction with a compartmental pharmacokinetic model, was used for study of factors influencing drug concentrations in urine: urine flow rate, residual bladder urine, maximal bladder urine, stage of renal failure, and elimination kinetics of drugs. Norfloxacin (NOR) was used ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Primozic S,Karba R,Mrhar A,Drinovec J,Kozjek F

    更新日期:1991-01-01 00:00:00